Consensus Enlivex Deutsche Boerse AG

Stocks

1BT

IL0011319527

Market Closed - Deutsche Boerse AG 07:08:29 28/08/2026 BST			After hours 21:02:56
1.250 ^EUR	-3.85%		1.180	-5.60%

07-28	Enlivex Ltd. announced that it expects to receive $400 million in funding	CI
07-13	Enlivex Receives FDA Regenerative Medicine Advanced Therapy Designation for Allocetra in Age-Related Knee Osteoarthritis	CI

Evolution of the Average Target: Enlivex

Evolution of the Target Price: Enlivex

Changes in Analyst Recommendations: Enlivex

fbe099dee48fe901b0b5bce2e8.WdIZKk-37xAA0jeZp4F2NHLoj_Dlk6EG5nrLMTEZk90.PKF2ZQDdnydHtE_KyqwefCuHvZWK3sResD6Pbn1o3r8xm0xFHPnZaU6kRA~50f86bc34e0d27ffa57eae9b455c431f

Analysts' recommendations: Enlivex

11/06/24	HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating	MT
12/04/24	HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating	MT
25/09/23	HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating	MT
02/05/22	HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.475USD

Average target price

80.00USD

Spread / Average Target

+5,323.73%

High Price Target

80.00USD

Spread / Highest target

+5,323.73%

Low Price Target

80.00USD

Spread / Lowest Target

+5,323.73%

Analyst Consensus Detail

Consensus revision (last 18 months)

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!

×